Thomas Kellerth

4.6k total citations · 2 hit papers
30 papers, 875 citations indexed

About

Thomas Kellerth is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Thomas Kellerth has authored 30 papers receiving a total of 875 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Cardiology and Cardiovascular Medicine, 12 papers in Radiology, Nuclear Medicine and Imaging and 11 papers in Surgery. Recurrent topics in Thomas Kellerth's work include Acute Myocardial Infarction Research (17 papers), Cardiac Imaging and Diagnostics (11 papers) and Coronary Interventions and Diagnostics (10 papers). Thomas Kellerth is often cited by papers focused on Acute Myocardial Infarction Research (17 papers), Cardiac Imaging and Diagnostics (11 papers) and Coronary Interventions and Diagnostics (10 papers). Thomas Kellerth collaborates with scholars based in Sweden, Denmark and United Kingdom. Thomas Kellerth's co-authors include David Erlinge, Joakim Alfredsson, Tomas Jernberg, Troels Yndigegn, Bertil Lindahl, Annica Ravn‐Fischer, Claes Held, Stefan James, Karolina Szummer and Lars Wallentin and has published in prestigious journals such as New England Journal of Medicine, Journal of the American College of Cardiology and European Heart Journal.

In The Last Decade

Thomas Kellerth

30 papers receiving 857 citations

Hit Papers

Improved outcomes in patients with ST-elevation myocardia... 2017 2026 2020 2023 2017 2024 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Kellerth Sweden 12 655 328 272 63 63 30 875
Pontus Andell Sweden 18 732 1.1× 300 0.9× 168 0.6× 216 3.4× 61 1.0× 59 1.1k
R. Thomas Tilbury United States 8 585 0.9× 213 0.6× 197 0.7× 75 1.2× 11 0.2× 12 716
Þórarinn Guðnason Iceland 13 308 0.5× 140 0.4× 93 0.3× 32 0.5× 15 0.2× 27 549
Neal A. Chatterjee United States 21 852 1.3× 108 0.3× 60 0.2× 77 1.2× 70 1.1× 64 1.1k
Rachel Kasper United States 9 460 0.7× 177 0.5× 196 0.7× 32 0.5× 40 0.6× 15 737
Erik Gjertsen Norway 15 720 1.1× 369 1.1× 187 0.7× 16 0.3× 16 0.3× 28 840
G. Nelson United Kingdom 15 785 1.2× 302 0.9× 242 0.9× 80 1.3× 90 1.4× 71 958
Robin Hofmann Sweden 17 546 0.8× 219 0.7× 158 0.6× 95 1.5× 92 1.5× 62 906
Michał Peller Poland 17 591 0.9× 110 0.3× 93 0.3× 73 1.2× 33 0.5× 82 827
Lasse Jespersen Denmark 8 903 1.4× 402 1.2× 688 2.5× 58 0.9× 9 0.1× 15 1.2k

Countries citing papers authored by Thomas Kellerth

Since Specialization
Citations

This map shows the geographic impact of Thomas Kellerth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Kellerth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Kellerth more than expected).

Fields of papers citing papers by Thomas Kellerth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Kellerth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Kellerth. The network helps show where Thomas Kellerth may publish in the future.

Co-authorship network of co-authors of Thomas Kellerth

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Kellerth. A scholar is included among the top collaborators of Thomas Kellerth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Kellerth. Thomas Kellerth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yndigegn, Troels, Bertil Lindahl, Joakim Alfredsson, et al.. (2024). Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction. New England Journal of Medicine. 390(15). 1372–1381. 99 indexed citations breakdown →
2.
Jönsson, Martin, Patric Karlström, Jörg Lauermann, et al.. (2024). Effects of beta-blockers on quality of life and well-being in patients with myocardial infarction and preserved left ventricular function—a prespecified substudy from REDUCE-AMI. European Heart Journal - Cardiovascular Pharmacotherapy. 10(8). 708–718. 5 indexed citations
3.
Desta, Liyew, Anna Lundberg, Joakim Alfredsson, et al.. (2023). Prevalence and Prognostic Impact of Left Ventricular Systolic Dysfunction or Pulmonary Congestion After Acute Myocardial Infarction. ESC Heart Failure. 10(2). 1347–1357. 10 indexed citations
4.
Yndigegn, Troels, Bertil Lindahl, Joakim Alfredsson, et al.. (2022). Design and rationale of randomized evaluation of decreased usage of beta-blockers after acute myocardial infarction (REDUCE-AMI). European Heart Journal - Cardiovascular Pharmacotherapy. 9(2). 192–197. 15 indexed citations
5.
Pagonis, Christos, Dimitrios Venetsanos, Eva Swahn, et al.. (2022). Nationwide observational study of incidence, management and outcome of spontaneous coronary artery dissection: a report from the Swedish Coronary Angiography and Angioplasty register. BMJ Open. 12(6). e060949–e060949. 7 indexed citations
6.
McEntegart, Margaret, Niels Ramsing Holm, Keith G. Oldroyd, et al.. (2022). Sex-Specific Clinical Outcomes After Treatment of Left Main Coronary Artery Disease. A NOBLE Substudy. Journal of the Society for Cardiovascular Angiography & Interventions. 1(4). 100338–100338. 4 indexed citations
7.
Hofmann, Robin, Tamrat Befekadu Abebe, Johan Herlitz, et al.. (2022). Avoiding Routine Oxygen Therapy in Patients With Myocardial Infarction Saves Significant Expenditure for the Health Care System—Insights From the Randomized DETO2X-AMI Trial. Frontiers in Public Health. 9. 711222–711222. 2 indexed citations
8.
Lindahl, Bertil, Johan Herlitz, Joakim Alfredsson, et al.. (2021). Poor long‐term prognosis in patients admitted with strong suspicion of acute myocardial infarction but discharged with another diagnosis. Journal of Internal Medicine. 290(2). 359–372. 2 indexed citations
9.
Hofmann, Robin, Tamrat Befekadu Abebe, Johan Herlitz, et al.. (2021). Routine Oxygen Therapy Does Not Improve Health-Related Quality of Life in Patients With Acute Myocardial Infarction—Insights From the Randomized DETO2X-AMI Trial. Frontiers in Cardiovascular Medicine. 8. 638829–638829. 6 indexed citations
10.
Ladwiniec, Andrew, Simon Walsh, Niels Ramsing Holm, et al.. (2020). Intravascular ultrasound to guide left main stem intervention: a NOBLE trial substudy. EuroIntervention. 16(3). 201–209. 45 indexed citations
11.
Thim, Troels, Matthias Götberg, Ole Fröbert, et al.. (2020). Agreement between nonculprit stenosis follow-up iFR and FFR after STEMI (iSTEMI substudy). BMC Research Notes. 13(1). 410–410. 2 indexed citations
12.
Jernberg, Tomas, Elmir Ömerovic, Krister Lindmark, et al.. (2020). Prevalence and prognostic impact of left ventricular systolic dysfunction after acute myocardial infarction. European Heart Journal. 41(Supplement_2). 4 indexed citations
13.
Wallentin, Lars, Joakim Alfredsson, David Erlinge, et al.. (2019). Temporal trends in bleeding events in acute myocardial infarction: insights from the SWEDEHEART registry. European Heart Journal. 41(7). 833–843. 46 indexed citations
14.
Palma, Rodney De, Henrik Bjursten, Pétur Pétursson, et al.. (2019). Change in mitral regurgitation severity impacts survival after transcatheter aortic valve replacement. International Journal of Cardiology. 294. 32–36. 24 indexed citations
15.
Thim, Troels, Matthias Götberg, Ole Fröbert, et al.. (2017). Nonculprit Stenosis Evaluation Using Instantaneous Wave-Free Ratio in Patients With ST-Segment Elevation Myocardial Infarction. JACC: Cardiovascular Interventions. 10(24). 2528–2535. 47 indexed citations
16.
Olivecrona, Göran, Bo Lagerqvist, Ole Fröbert, et al.. (2016). Impact of thrombus aspiration during ST-Elevation Myocardial Infarction: a six month composite endpoint and risk of stroke analyses of the TASTE trial. BMC Cardiovascular Disorders. 16(1). 62–62. 8 indexed citations
17.
Hambræus, Kristina, Karin Jensevik, Bo Lagerqvist, et al.. (2016). Long-Term Outcome of Incomplete Revascularization After Percutaneous Coronary Intervention in SCAAR (Swedish Coronary Angiography and Angioplasty Registry). JACC: Cardiovascular Interventions. 9(3). 207–215. 34 indexed citations
18.
Kellerth, Thomas, et al.. (2013). Left bundle branch block and suspected myocardial infarction: does chronicity of the branch block matter?. European Heart Journal Acute Cardiovascular Care. 2(2). 182–189. 8 indexed citations
19.
Vikman, Saila, Lisette Okkels Jensen, Jens Flensted Lassen, et al.. (2012). Intravascular ultrasound assessed incomplete stent apposition and stent fracture in stent thrombosis after bare metal versus drug-eluting stent treatment the Nordic Intravascular Ultrasound Study (NIVUS). International Journal of Cardiology. 168(2). 1010–1016. 22 indexed citations
20.
Christiansen, Frank, et al.. (1996). Ultrasound at Scintigraphic “Intermediate Probability of Pulmonary Embolism”. Acta Radiologica. 37(1P1). 14–17. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026